Few High-Risk Mothers in Boston Took Folic Acid Before Pregnancy
Group was mostly low-income, minority; one-third had too-low or too-high plasma folate levels
Read MoreJun 4, 2018
Group was mostly low-income, minority; one-third had too-low or too-high plasma folate levels
Read MoreJun 4, 2018
Using implicit and explicit measures, researchers find negative bias toward frozen versus fresh vegetables
Read MoreJun 4, 2018
In year 1, 13 percent did not undergo MRI or mammography; up to 19 percent by year 5
Read MoreJun 4, 2018
48-year-old woman taking biotin had abnormal results for multiple tests, including total testosterone
Read MoreJun 4, 2018
Higher lifetime and last-30-day substance use rates seen, particularly among 8th graders
Read MoreJun 4, 2018
Improved overall survival versus chemotherapy regardless of the PD-L1 tumor proportion score
Read MoreJun 4, 2018
No significant difference between regions in median OS for those receiving, not receiving systemic tx
Read MoreJun 4, 2018
Most frequently reported adverse events included injection site erythema and swelling, pyrexia
Read MoreJun 4, 2018
Use of updated equations would relabel about 11.8 million high-risk U.S. adults as lower-risk
Read MoreJun 4, 2018
Adaptive transfer of mutant-protein-specific tumor-infiltrating lymphocytes leads to disease regression
Read MoreJun 4, 2018
Sunitinib alone noninferior to nephrectomy plus sunitinib with respect to overall survival
Read MoreJun 4, 2018
Similar efficacy for endocrine, chemoendocrine tx for women with midrange 21-gene recurrence score
Read MoreJun 4, 2018
And, pre-op chemoradiotherapy linked to longer overall survival than immediate surgery
Read MoreJun 1, 2018
Here are what the editors at HealthDay consider to be the most important developments in Allergy for May 2018. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice. ASHP: SVP, Injectable Opioid Shortages Threaten Patient Care […]
Read MoreJun 1, 2018
Here are what the editors at HealthDay consider to be the most important developments in Cardiology for May 2018. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice. No Consistent Cardiovascular Benefit Seen for Supplements THURSDAY, […]
Read MoreJun 1, 2018
Here are what the editors at HealthDay consider to be the most important developments in Dermatology for May 2018. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice. Oral Propranolol Seems Safe for Infantile Hemangioma THURSDAY, […]
Read MoreJun 1, 2018
Here are what the editors at HealthDay consider to be the most important developments in Diabetes & Endocrinology for May 2018. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice. ASHP: SVP, Injectable Opioid Shortages Threaten […]
Read MoreJun 1, 2018
Here are what the editors at HealthDay consider to be the most important developments in Family Practice for May 2018. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice. No Consistent Cardiovascular Benefit Seen for Supplements […]
Read MoreJun 1, 2018
Here are what the editors at HealthDay consider to be the most important developments in Gastroenterology for May 2018. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice. ASHP: SVP, Injectable Opioid Shortages Threaten Patient Care […]
Read MoreJun 1, 2018
Here are what the editors at HealthDay consider to be the most important developments in HIV & AIDS for May 2018. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice. ASHP: SVP, Injectable Opioid Shortages Threaten […]
Read More